Which disease shows a cyclical trend?
A person is considered as a case of tuberculosis if which of the following conditions are met?
A 3-year-old, completely unimmunized child presents to a primary health center immunization clinic for the first time. Which vaccines should be administered?
What does the 3rd stage of the demographic transition indicate?
A couple has 4 unvaccinated children for measles. One child contracted measles on August 5th, 2015, and two other children developed measles by August 15th, 2015. What is the secondary attack rate in this scenario?
Which of the following rates is an indicator of both mortality and the living standard of a community?
What is the main period of communicability of whooping cough?
What does prevalence describe in epidemiology?
Which of the following influenza subtypes led to an outbreak in China in 2013?
Which of the following diseases has an incubation period of less than 10 days?
Explanation: **Explanation:** In epidemiology, time trends of disease occurrence are classified into several patterns. **Cyclical trends** refer to the recurrent variations in disease incidence that occur over short periods (usually 2–3 years) rather than annually. **1. Why Measles is the correct answer:** Measles classically exhibits a cyclical trend. This occurs because the disease requires a critical mass of susceptible individuals (the "herd") to spread. After an outbreak, the number of susceptible children decreases due to acquired immunity. It then takes **2 to 3 years** for a new cohort of susceptible children to be born or accumulate, reaching a threshold that triggers the next epidemic cycle. In the pre-vaccination era, this 2-year cycle was very distinct. **2. Analysis of Incorrect Options:** * **Malaria & Diarrhea:** These diseases primarily show **Seasonal Trends**. Their incidence peaks during specific times of the year (e.g., Malaria during the monsoon due to vector breeding; Diarrhea during summer/monsoon). While they recur, the periodicity is annual, not cyclical. * **Tuberculosis:** This disease follows a **Secular Trend**. Secular trends describe consistent, long-term changes in disease occurrence over decades (e.g., the gradual decline of TB in developed nations due to improved living standards and treatment). **High-Yield NEET-PG Pearls:** * **Secular Trend:** Long-term (e.g., TB, Cardiovascular diseases). * **Cyclical Trend:** 2–3 years (e.g., Measles, Rubella, Influenza Type A). * **Seasonal Trend:** Within one year (e.g., Cholera, Dengue). * **Point Source Epidemic:** All cases occur within one incubation period (e.g., Food poisoning).
Explanation: In epidemiology and public health programs like the **National TB Elimination Programme (NTEP)**, the definition of a "case" is crucial for surveillance and treatment initiation. ### **Why "Sputum Positive" is the Correct Answer** In the context of tuberculosis epidemiology, a **"Case"** is defined as a person in whom tuberculosis has been bacteriologically confirmed or clinically diagnosed by a clinician. Among the options provided, **Sputum Positive (Bacteriological confirmation)** is the "Gold Standard" for defining a case. It confirms the presence of *Mycobacterium tuberculosis*, making the individual a "definite case" who is infectious and requires immediate chemotherapy to break the chain of transmission. ### **Why Other Options are Incorrect** * **A. Has cough:** This is a **symptom**, not a diagnosis. Cough for >2 weeks makes a person a "Presumptive TB case" (formerly TB Suspect), but not a confirmed case. * **C. X-ray signs suggestive of TB:** Radiology is sensitive but not specific. Many conditions (fungal infections, pneumonia, old scars) can mimic TB. While it helps in "Clinically Diagnosed" cases, it is secondary to bacteriological confirmation. * **D. Mantoux test positive:** This indicates **Latent TB Infection (LTBI)** or prior exposure/BCG vaccination. It does not differentiate between active disease and past infection; therefore, it cannot define a clinical "case." ### **High-Yield Clinical Pearls for NEET-PG** * **Microscopy vs. Molecular:** Under NTEP, **NAAT (CBNAAT/Truenat)** is now the preferred first-line diagnostic tool over traditional sputum microscopy. * **Infectivity:** A single sputum-positive patient can infect 10–15 people in a year if left untreated. * **Presumptive TB:** Any person with a cough of 2 weeks or more, fever, night sweats, or significant weight loss. * **Gold Standard for Diagnosis:** Culture remains the absolute gold standard, but for rapid programmatic definition, Sputum/NAAT positivity is used.
Explanation: ### Explanation This question tests the application of the **National Immunization Schedule (NIS)** guidelines for "catch-up" vaccination in an unimmunized child. **1. Why Option B is Correct:** The core principle here is the age-specific cutoff for certain vaccines: * **BCG:** Can only be given up to **1 year of age**. Since the child is 3 years old, BCG is no longer indicated. * **DPT vs. DT:** The Pertussis component (in DPT) is associated with an increased risk of adverse reactions (like febrile seizures or encephalopathy) as the child grows older. According to the NIS, the Pertussis component is generally not started after age 2. Therefore, for a child between **2 to 7 years**, **DT (Dual Antigen)** is administered instead of DPT. * **OPV, Measles (MR), and Vitamin A:** These are indicated as part of the primary series catch-up. **2. Why Other Options are Wrong:** * **Option A:** Incorrect because it includes BCG (contraindicated after 1 year) and misses essential vaccines like DT and OPV. * **Option C:** Incorrect because it includes both BCG and DPT. DPT is replaced by DT in this age group. * **Option D:** Incorrect because it lists DPT instead of DT. **3. High-Yield NEET-PG Pearls:** * **BCG Cutoff:** Birth to 1 year (0.05ml if <1 month; 0.1ml if 1 month to 1 year). * **DPT Cutoff:** Should not be started if the child is >2 years old; use DT instead. * **Measles/MR:** Can be given up to 5 years of age under the routine schedule. * **Vitamin A:** First dose at 9 months (1 lakh IU), subsequent doses every 6 months up to 5 years (2 lakh IU). Total 9 doses. * **JE Vaccine:** Can be given up to 15 years in endemic areas.
Explanation: ### Explanation The **Demographic Transition Model** describes the historical shift from high birth and death rates to low birth and death rates as a country develops. **1. Why the correct answer is right:** In the **3rd Stage (Late Expanding)**, the birth rate begins to fall significantly. This is usually due to increased access to contraception, urbanization, and improved female literacy. Simultaneously, the death rate continues to decline further due to better medical facilities and sanitation. However, because the birth rate is still higher than the death rate, the population continues to grow, albeit at a slower pace. **2. Analysis of incorrect options:** * **Option A (High birth and death rate):** This describes **Stage 1 (High Stationary)**. Here, the population remains stable but at a low level because high fertility is offset by high mortality (epidemics, famine). * **Option B & C (Death rate declines while birth rate remains unchanged):** This describes **Stage 2 (Early Expanding)**. This stage is characterized by a "population explosion" because the death rate drops rapidly due to improved healthcare, but social norms keep the birth rate high. **3. High-Yield NEET-PG Pearls:** * **India’s Status:** India is currently in **late Stage 3** of the demographic transition. * **Stage 4 (Low Stationary):** Characterized by low birth and low death rates (e.g., many developed European nations). * **Stage 5 (Declining):** Birth rate falls below the death rate, leading to a negative population growth rate (e.g., Germany, Japan). * **Key Indicator:** The transition from Stage 2 to Stage 3 is primarily marked by a **decline in fertility (Birth Rate)**.
Explanation: ### Explanation **Secondary Attack Rate (SAR)** is a measure of the spread of a communicable disease among susceptible contacts within a closed group (like a household) following the introduction of an index case. **1. Why 66% is Correct:** The formula for SAR is: $$\text{SAR} = \frac{\text{Number of secondary cases}}{\text{Total number of susceptible contacts}} \times 100$$ * **Index Case:** The first child who contracted measles on August 5th. This child is the source, not a secondary case. * **Susceptible Contacts:** The remaining 3 unvaccinated children in the household. * **Secondary Cases:** The 2 children who developed measles by August 15th (within the incubation period of the index case). * **Calculation:** $\frac{2}{3} \times 100 = 66.6\% \approx 66\%$. **2. Why Other Options are Incorrect:** * **A (75%):** This incorrectly includes the index case in the numerator ($\frac{3}{4}$). SAR only counts cases that occur *after* the initial exposure. * **C (33%):** This assumes only one child was infected as a secondary case, which contradicts the data. * **D (0%):** This would imply no transmission occurred within the household. **3. Clinical Pearls for NEET-PG:** * **Denominator Rule:** Always exclude the index case from both the numerator and the denominator. * **Susceptibility:** Only "at-risk" individuals are included. If a child were already vaccinated or had prior measles, they would be excluded from the denominator. * **Measles SAR:** Measles is highly contagious; in unvaccinated household settings, the SAR typically exceeds 80-90%. * **Utility:** SAR is used to determine the **infectivity** of a pathogen and the effectiveness of control measures (like post-exposure prophylaxis).
Explanation: **Explanation:** **1. Why Infant Mortality Rate (IMR) is the correct answer:** The Infant Mortality Rate (defined as the number of deaths of children under 1 year of age per 1,000 live births) is widely regarded as the **most sensitive indicator** of the health status of a community. It reflects not only the quality of pediatric and maternal healthcare but also the overall **socio-economic development and living standards**. This is because infant survival is heavily influenced by environmental factors such as sanitation, clean water, nutrition, and housing, as well as the educational status of the mother. **2. Why the other options are incorrect:** * **Postnatal Mortality Rate (PNMR):** While it reflects environmental and nutritional factors, it excludes the neonatal period (first 28 days), where the majority of infant deaths occur due to biological and birth-related factors. * **Maternal Mortality Rate (MMR):** This primarily reflects the efficiency of obstetric services and the status of women in society, rather than the general living standard of the entire community. * **Crude Death Rate (CDR):** This is a very "crude" measure because it is heavily influenced by the age structure of the population. A developed country with an aging population may have a higher CDR than a developing country with a young population. **3. High-Yield Clinical Pearls for NEET-PG:** * **IMR Formula:** (Number of deaths < 1 year / Total Live Births) × 1000. * **Neonatal Mortality Rate (NMR):** Most sensitive indicator of **availability and utilization of antenatal and natal care.** * **Under-5 Mortality Rate:** Best indicator of **social development and child health.** * **Physical Quality of Life Index (PQLI):** Includes IMR, Life Expectancy at Age 1, and Literacy. (Note: It does *not* include Income/GNP).
Explanation: **Explanation:** The period of communicability for Whooping Cough (*Bordetella pertussis*) is most intense during the **Catarrhal stage**. This stage, which lasts about 1–2 weeks, is characterized by non-specific respiratory symptoms (coryza, sneezing, low-grade fever) and a high concentration of bacteria in the nasopharyngeal secretions. Because the symptoms mimic a common cold, patients often remain active in the community, facilitating rapid transmission via respiratory droplets. **Analysis of Options:** * **Catarrhal stage (Correct):** This is the peak period of infectivity. The bacterial load is highest, and the cough has not yet become paroxysmal, making it the most infectious phase. * **Incubation period:** This is the time from exposure to the onset of symptoms (usually 7–10 days). The patient is generally not infectious during this silent phase. * **Paroxysmal stage:** While the patient is still infectious during the first 2–3 weeks of this stage, the communicability progressively declines as the bacterial load decreases, despite the worsening severity of the "whoop." * **Convalescent stage:** By this stage (weeks 4+), the patient is typically no longer infectious, as the bacteria have been cleared, although the cough may persist for months ("100-day cough"). **High-Yield Clinical Pearls for NEET-PG:** * **Secondary Attack Rate (SAR):** Approximately 80–90% among susceptible household contacts. * **Drug of Choice:** Erythromycin (or other Macrolides like Azithromycin) for 7–14 days. * **Effect of Antibiotics:** If started in the catarrhal stage, they can abort or modify the disease. If started in the paroxysmal stage, they do not change the clinical course but **do** reduce communicability. * **Isolation:** Cases should be isolated for 5 days after starting effective antibiotic therapy.
Explanation: **Explanation:** **Prevalence** refers to the total number of all individuals (both old and new cases) who have a disease at a particular point in time or over a specified period. **Why Option D is correct:** Prevalence is not a static figure; it is a dynamic "pool" influenced by three main factors. It increases with new cases (**Incidence**) and decreases when individuals leave the pool through either **Recovery** or **Death (Mortality)**. Mathematically, for diseases with a stable course, the relationship is expressed as: **Prevalence (P) = Incidence (I) × Mean Duration of disease (D).** Since duration is determined by how quickly patients recover or die, prevalence represents the net balance of these variables. **Analysis of Incorrect Options:** * **Option A:** Incidence, not prevalence, is the best measure for etiological (causative) studies because it focuses on the transition from health to disease. * **Option B:** Prevalence is determined by **Cross-sectional studies** (also known as Prevalence Studies). Cohort studies are used to determine Incidence. * **Option C:** The number of *new* cases is the definition of **Incidence**. Prevalence includes both *new and old* cases. **High-Yield Clinical Pearls for NEET-PG:** * **Point Prevalence:** Cases at a single point in time (e.g., "Do you have the flu today?"). * **Period Prevalence:** Cases over a period of time (e.g., "Have you had the flu in the last year?"). * **Factors increasing prevalence:** Longer duration of illness, prolongation of life without a cure, increase in new cases (incidence), and in-migration of cases. * **Factors decreasing prevalence:** High fatality rate, quick recovery, and out-migration of cases.
Explanation: ### Explanation **Correct Option: D (H7N9)** The **H7N9** virus is a subtype of Avian Influenza that was first reported to cause human infections in **China in March 2013**. Unlike highly pathogenic avian influenza (like H5N1), H7N9 is unique because it causes severe respiratory illness in humans (pneumonia and ARDS) but remains "low pathogenic" in poultry, making it difficult to detect in bird populations before it jumps to humans. This outbreak was significant due to its high mortality rate (approx. 30-40%) and its association with live bird markets. **Analysis of Incorrect Options:** * **A. H1N1:** Responsible for the **1918 Spanish Flu** pandemic and the **2009 Swine Flu** pandemic. While endemic globally, it was not the "new" outbreak subtype of 2013. * **B. H3N2:** This is a common subtype of seasonal influenza that caused the **1968 Hong Kong Flu** pandemic. It circulates annually as part of the seasonal flu profile. * **C. H2N2:** This subtype caused the **1957 Asian Flu** pandemic. It has not circulated in the human population since 1968. **High-Yield Clinical Pearls for NEET-PG:** * **Antigenic Shift:** Major genetic changes resulting in new subtypes (e.g., H1N1 to H2N2), leading to **Pandemics**. * **Antigenic Drift:** Minor point mutations causing seasonal variations, leading to **Epidemics**. * **Drug of Choice:** Oseltamivir (Neuraminidase inhibitor) is the standard treatment for both seasonal and avian influenza. * **H5N1:** Another major Avian Flu (Bird Flu) subtype, first seen in Hong Kong (1997), known for very high human lethality.
Explanation: **Explanation:** The **Incubation Period (IP)** is the interval between the invasion of an infectious agent and the appearance of the first sign or symptom of the disease. Understanding IP is crucial for quarantine, contact tracing, and outbreak investigation in Epidemiology. **Why Influenza is the correct answer:** Influenza is characterized by a very short incubation period, typically ranging from **1 to 4 days** (average 2 days). This rapid onset is a hallmark of respiratory viral infections that replicate in the upper respiratory tract, allowing for swift transmission and explosive outbreaks. **Analysis of Incorrect Options:** * **Cholera:** While Cholera has a very short IP (typically **1 to 5 days**), the question asks for a disease with an IP of *less than 10 days*. However, in the context of standard NEET-PG MCQ patterns, Influenza is often prioritized as the "shortest" among common respiratory infections. *Note: Both Influenza and Cholera technically fit the "less than 10 days" criteria, but Influenza is the classic textbook answer for ultra-short IP.* * **Plague:** The IP for Bubonic plague is generally **2 to 6 days**, but Pneumonic plague is even shorter (1 to 3 days). However, Influenza remains the more common epidemiological reference for this category. * **Chickenpox (Varicella):** This is definitely incorrect as it has a long IP, typically **14 to 16 days** (range 10–21 days). **High-Yield Clinical Pearls for NEET-PG:** * **Shortest IP:** Influenza, Cholera, Bacillary Dysentery (hours to days). * **Longest IP:** Leprosy (3–5 years), Filariasis (8–12 months), Rabies (variable, usually 1–3 months). * **Median IP:** Useful for determining the time of exposure during a point-source outbreak. * **Quarantine Period:** Usually fixed at the **maximum** incubation period of the disease.
Principles of Epidemiology
Practice Questions
Measures of Disease Frequency
Practice Questions
Epidemiological Study Designs
Practice Questions
Descriptive Epidemiology
Practice Questions
Analytical Epidemiology
Practice Questions
Experimental Epidemiology
Practice Questions
Screening for Disease
Practice Questions
Surveillance Systems
Practice Questions
Investigation of an Epidemic
Practice Questions
Association and Causation
Practice Questions
Modern Epidemiological Methods
Practice Questions
Critical Appraisal of Epidemiological Studies
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free